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The patient with diabetes mel-
litus who becomes unconscious 
presents a problem in differential 
diagnosis. We now recognize six 
possible causes of coma in the dia-
betic patient. These include the 
usual diabetic keto-acidosis, and 
five possible non-ketotic causes: 
I. Keto-acidosis 
II. Non-ketotic causes of coma 
A. Unconsciousness unrelated 
to diabetes, e.g. barbiturate 
intoxication, "stroke," ure-
mia 
B. Hypoglycemia 
C. Lactic acidosis 
D. Hypernatremia 
E. Hyperglycemia 
Of the non-ketotic types, the first 
may be considered to be a coinci-
dence of unrelated events in a dia-
betic patient, i.e., diabetes plays no 
direct and immediate causal role in 
the coma. 
Hypoglycemic coma most com-
monly follows excessive dosage of 
insulin, but may also be caused by 
the oral hypoglycemic agents, espe-
cially in patients with impaired renal 
function who do not excrete the 
sulfonylureas well. Hypoglycemia 
four to five hours after eating also 
may be a manifestation of early, 
untreated diabetes, with delayed se-
cretion of insulin by the pancreas. 
Lactic acidosis results from tissue 
hypoxia, with inability to convert 
lactate to pyruvate, the accumula-
tion of lactic acid resulting in aci-
dosis. This is most often seen in 
patients who have been in pro-
longed shock, as from slow bleed-
ing or from myocardial infarction. 
Often they have an alcoholic his-
tory. The prolonged shock with tis-
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sue hypoxia causes excessive pro-
duction of lactic acid, which is not 
adequately removed by the liver. 
The serum bicarbonate and pH are 
down, but no acetone is present in 
the urine or in the plasma. 
Hypernatremic coma and hyper-
glycemic coma are both produced 
by cellular dehydration resulting 
from excessive hyperosmolarity of 
the extracellular fluid . Generally in 
hypernatremic coma serum sodium 
levels are as high as 156 to 188 
mEq/ liter. Hyperglycemic coma is 
characterized by blood sugar levels 
of 600 to 1000 mg% or higher. 
Hyperosmolar coma occurs chiefly 
in older individuals. Their diabetes 
is often of recent onset, with no 
treatment or inadequate treatment, 
and a slow development of stupor 
and unconsciousness. Treatment 
consists of the administration of 
hypotonic fluids and insulin as 
needed. These patients do not have 
the extreme resistance to insulin 
seen in keto-acidosis, and the 
amount of insulin required is usu-
ally much less than in keto-acidotic 
coma. 
In the patient who develops keto-
acidosis, a shortage of insulin is the 
key defect. This shortage can arise 
from a variety of circumstances, 
such as undiagnosed, untreated dia-
betes, omission of insulin in the 
known diabetic, or failure to meet 
the increasing requirement for in-
sulin caused by infection, inactivity, 
or emotional disturbances. We rec-
ognize that the key ingredient in 
therapy is insulin. However, as the 
acidosis develops, there occur a 
number of changes in extracellular 
and intracellular fluid and electro-
lytes. I would like to spend a little 
time discussing these because they 
represent important facets of this 
disturbance. 
FLUID AND ELECTROLYTE 
DISTURBANCES 
Depletion of Cell Potassium 
Patients who develop keto-acido-
sis usually have anorexia and 
vomiting. Obviously, anything that 
interferes with the intake of food 
and fluids will interfere with the 
intake of potassium, so that the 
ordinary supply of potassium is cut 
off. At the same time, the interrup-
tion of glycolysis, a source of en-
ergy for maintenance of the intra-
cellular distribution of potassium, 
results in a leaking out of potassium 
from the cells. Also, because pa-
tients with keto-acidosis are not 
eating, they will have a negative 
nitrogen balance. Cell protein is 
ordinarily laid down in a propor-
tion of lg of nitrogen to 3 mEq of 
potassium. When a negative nitro-
gen balance occurs, potassium is 
lost from the cells. Also, the patient 
in diabetic keto-acidosis is not stor-
ing carbohydrate in the liver as 
glycogen. This process ordinarily 
removes from the extracellular fluid 
a certain amount of potassium. As 
the liver becomes deglycogenated in 
the keto-acidotic patient, this potas-
sium is released. So we now have 
three processes transferring potas-
sium from the cells into the extra-
cellular fluid; loss of the pump ef-
fect, negative nitrogen balance, and 
deglycogenation of the liver. 
The so-called "dehydration re-
action" is a fourth cause of potas-
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sium loss from cells. These pa-
tients become dehydrated, first of 
all because they are not taking 
fluids. At the same time, they usu-
ally have an osmotic diuresis and 
continue to lose fluids from the skin 
and through the lungs. As dehydra-
tion progresses, the body tries to 
maintain the integrity of the extra-
cellular and intracellular fluid as 
close to normal as possible. Most of 
the losses are from the extracellular 
fluid in the initial phase, but ulti-
mately transfers from cells to ex-
tracellular fluid occur. A variety of 
mechanisms bring these transfers 
about. First, as the tonicity of the 
extracellular fluid rises because of 
hyperglycemia, water is drawn out 
of the cells. Secondly, there is a de-
hydration reaction which permits 
the release of potassium from cells 
and with it a modicum of water. In 
other words, the transfer of potas-
sium out of the cells reduces the 
osmolarity of the cells and raises 
the osmolarity of the extracellular 
fluid, and therefore water is trans-
ferred with the potassium. These 
mechanisms serve to prevent exces-
sive depletion of extracellular fluid, 
but at the same time they deprive 
the cells further of potassium. 
That a deficit of cell potassium 
of sufficient degree produces histo-
logic evidence of cell destruction is 
clearly demonstrable in heart and 
skeletal muscle. Interference with 
normal cell function by potassium 
depletion is recognized in electro-
cardiographic changes, and in al-
tered function of the nervous sys-
tem, the gastrointestinal tract, and 
the kidneys. But more important 
than any of these is that potassium 
deficits within the cell are associ-
ated with increased mortality. This 
is amply demonstrated in animal 
studies and has its counterpart in 
the clinical situation. 
Serum Potassium Levels 
Although the patient with dia-
betic keto-acidosis is markedly de-
pleted of potassium, the initial 
level of serum potassium is often 
high. This is because, during the 
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development of keto-acidosis, po-
tassium has been transferred from 
cells into the extracellular fluid, 
and as dehydration and decreased 
renal blood flow diminish the urine 
output, potassium may not be well 
excreted. With fluid replacement 
and insulin treatment, potassium 
will quickly re-enter the cells and 
the serum potassium may drop 
sharply during the first few hours 
of treatment. In children, the ini-
tial serum potassium levels are not 
so often elevated, but may be nor-
mal or occasionally low. The rea-
son may be that in children there 
is possibly a greater osmotic diuresis 
and a more rapid excretion of the 
potassium that has passed from the 
cells into extracellular fluid. In 
either case a low initial serum po-
tassium level should alert one to 
the presence of very severe potas-
sium depletion and the danger of 
severe hypokalemia developing in 
the course of treatment. 
Sodium Loss, Dehydration, 
and Shock 
With respect to sodium, some of 
the comments already made con-
cerning potassium apply. The intake 
of this electrolyte is cut off, and 
further losses occur through vom-
iting and from renal loss as part of 
the osmotic diuresis. All these 
losses of sodium result in sodium 
depletion. When extracellular so-
dium is reduced by 25 % a prompt 
decrease in circulatory efficiency 
occurs. If sodium is lost from extra-
cellular fluid in excess of water, 
hypo-osmolarity of the extracellu-
lar fluid results. This causes water 
to move into the cells. This by it-
self has no particular significance, 
but the loss of circulating volume 
from the extracellular fluid, either 
by loss to the exterior or by trans-
fer into cells, results in circulatory 
inefficiency. With the reduction in 
plasma volume the hematocrit rises. 
There is slowing of the circulation, 
with diminished venous return, de-
creased cardiac output and in-
creased peripheral resistance. The 
end result is circulatory collapse, 
just as real as that which can fol-
low hemorrhage, extensive trauma, 
or any other cause. 
It is very important to recognize 
the occurrence of sodium deficits. 
Such deficits are invariably present 
but the signs of circulatory collapse 
may not be. I think surely all of 
us now realize that we can have 
circulatory inefficiency with a nor-
mal blood pressure. As the blood 
volume falls, the blood pressure 
can be maintained for a while by 
arteriolar constriction, but this will 
lessen the delivery of blood to the 
tissues, which in turn interferes 
with cell function. 
THERAPY 
Insulin 
The treatment of diabetic keto-
acidosis begins with insulin. Gen-
erally this can be given in the home 
before the patient is referred to the 
hospital. Time is of the essence and 
one has to make sure that valuable 
time is not lost transporting the pa-
tient to the hospital, getting him 
admitted, finding out about hospital 
insurance, etc., and moving him to 
his bed. How much insulin, what 
route of administration, frequency 
of dosage etc., you and I could dis-
cuss for a long time. I think it is 
interesting to recall that some 20 
years ago, Rabinowitz, in Montreal, 
routinely administered 200 units of 
insulin on admission and gave no 
further insulin, and in that particu-
lar series of patients all of them 
recovered. You and I are more apt 
to approach this problem in a 
gradual fashion, so to speak. We 
back into a final decision. Of course 
we can be a little bit more scien-
tific if we call it "the method of 
successive approximations toward 
the need," but fundamentally 
"chicken" is a better term. I think 
it is better to remember that you 
can quite safely give too much in-
sulin because you can counteract 
this subsequently by administering 
carbohydrate. But if you do not 
give enough insulin, the one thing 
that you cannot recapture is time. 
So, if you are going to make a mis-
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take, do so in a very bold fashion. 
Experience indicates that ordinarily 
300 or 500 units of insulin in the 
first 24 hours have proved to be 
adequate. This does not mean that 
there are not going to be patients 
that require a good deal more. Also 
you will have patients who will do 
well on a smaller quantity. This is 
an average figure and ordinarily in 
this "chicken" fashion, you will first 
administer 100 units as soon as the 
patient comes into the emergency 
room. This gives you a chance to 
get a little information as to the 
level of blood sugar, the decrease 
in "C02," the presence of plasma 
acetone, and the status of the cir-
culation. 
Fluids 
After withdrawing blood from 
one vein, you start an infusion of 
0.9% sodium chloride solution. 
There are many choices of so-
lutions. We still prefer sodium 
chloride. First it is generally avail-
able. Secondly, all of the solutions 
that are offered represent confusion 
in a sense. If you use Ringer's lac-
tate solution, it has a little bit of 
bicarbonate in it and it has a little 
bit of potassium and you may think 
you are doing something, but you 
are only deluding yourself. So we 
recommend beginning fluid replace-
ment with sodium chloride. It is a 
useful rule of thumb to keep in 
mind that an adult diabetic coma 
patient comes in with a water defi-
cit equal to 10% of the body weight, 
a sodium deficit of 10 mEq/ kg, a 
chloride deficit of 10 mEqjkg, and 
a potassium deficit of 5mEq/kg. 
This means that in an adult weigh-
ing 70 kg, on admission there is a 
deficit of 7 liters of water, 700 
mEq of sodium, 700 mEq of chlo-
ride, and 350 mEq of potassium. 
Our goal is not to replace these 
deficits at once. Our goal is one of 
turning the patient around and 
starting him toward recovery and 
away from death. The administra-
tion of sodium chloride following 
the initial dose of insulin provides 
an adequate beginning in most in-
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stances. Ordinarily it will be suffi-
cient to give two liters of sodium 
chloride, which contains approxi-
mately 18 g, or 308 mEq of sodium 
and of chloride. Please note that 
we are not trying to replace the to-
tal deficit of 700 mEq at once. We 
are giving part of it over the course 
of several hours. We recognize that 
during these several hours some of 
what we have administered will con-
tinue to be lost in the urine or by 
other routes. But it is enough just 
to turn the patient around. At the 
end of the 2 liters of saline, which 
will probably take some 3 hours to 
administer, one will have further 
laboratory data. At that point it 
may very well be that the labora-
tory indicates that the serum potas-
sium is now down to normal or be-
low normal, and at this point one 
can start therapy with potassium. 
Also laboratory reports will often 
indicate that the blood sugar is de-
creasing. At this point the potas-
sium can be administered in 5 % 
glucose. Generally it is desirable to 
use potassium phosphate rather 
than chloride. The reason for this 
is that we are using sodium chlo-
ride which has 154 mEq of chlo-
ride which is higher than the 
concentration normally present in 
extracellular fluid. We do not want 
to give KC! because we will be fur-
ther adding to the chloride load 
and in some patients a hyperchlo-
remic acidosis may result. The 
second reason is that patients with 
diabetic keto-acidosis develop defi-
cits of phosphate from lack of in-
take and from Joss of this solute in 
the urine. This phosphate does not 
come from the extracellular fluid; 
it comes from the cells. Some of it 
comes from protein breakdown, but 
the majority of it represents the 
breakdown of high-energy phos-
phate compounds such as ATP and 
creatine phosphate which are not 
being rebuilt because carbohydrate 
metabolism is reduced. No one has 
ever succeeded in demonstrating 
that these huge deficits of phos-
phate do any harm. Nonetheless, it 
does seem logical to give the potas-
sium replacement as buffered phos-
phate, both to help somewhat in re-
placement of phosphate, and to 
avoid adding to the chloride load. 
How much potassium would you 
give? If the total deficit is estimated 
to be 350 mEq, it would probably 
be enough to set as a goal the ad-
ministration of approximately one 
third of that over 3 or 4 hours, at 
the rate of approximately 40 mEq 
per hour. 
Glucose 
There has been great controversy 
in the past as to whether glucose 
should be given in the initial phase 
of treatment. Glucose solutions 
given even at the start of treatment 
do no harm except possibly to con-
tribute further to the osmotic di-
uresis. Glucose does help to replete 
liver glycogen and diminish the 
ketosis, but many prefer not to be-
gin glucose administration until 
there is definite evidence that the 
blood sugar has begun to fall with 
treatment. We should remember 
that even an initial blood sugar of 
500 mg% may not represent more 
than 50 or 60 g of total glucose in 
the extracellular fluid, and this 
amount can be put back into cells 
fairly quickly once enough insulin 
is given. It is imperative that glu-
cose be provided as the blood sugar 
falls, in amounts adequate to cover 
the large doses of insulin that have 
been given, and at a rate rapid 
enough to prevent hypoglycemia. 
Dextran and Alkalis 
It is a good rule in seriously ill 
patients to consider two additional 
elements in the early therapy. The 
first of these is the use of dextran, 
or less desirably, the use of whole 
blood or plasma. Whole blood or 
plasma is less desirable because of 
the problem of hepatitis. In patients 
on the verge of circulatory collapse 
or in actual circulatory collapse, a 
unit of dextran is a kind of insur-
ance and I would rather give it 
needlessly to 99 patients than fail 
to give it to the one who needs it. 
The second item is the use of alkali 
solutions shortly after admission. 
I like to reserve these for patients 
who have a reduction of the pH 
down to seven or so. The routine 
administration of alkali interferes 
with the use of "C02" (bicarbonate) 
as a precise index of improvement. 
It is very reassuring to find that a 
bicarbonate of 5 mEq/liter has risen 
after several hours of treatment to 
8 or 9 mEq/liter. I know that the 
patient is clearing ketone bodies 
and is responding to insulin. I can-
not tell this quite as precisely when 
one uses the plasma acetone or the 
urine acetone as the sole index. 
This index is lost when 6 molar lac-
tate or sodium bicarbonate is ad-
ministered. On the other hand if 
the pH is reduced sufficiently, we 
know that this by itself threatens 
survival, and under these circum-
stances one should give alkali. 
Use of Fructose 
Another point that deserves men-
tion is the use of fructose instead 
of glucose. Theoretically there are 
several advantages to fructose . First 
of all , it can enter the glycolytic 
cycle without the intervention of 
insulin. Secondly, it is an excellent 
glycogen former and, as we have 
indicated, hepatic glycogen is de-
pleted. Thirdly, the Tm for glucose 
and the Tm for fructose are inde-
pendent and non-additive. The kid-
neys reabsorb glucose and fructose 
independently, and therefore one 
can carry higher blood sugar levels 
with less glycosuria. All of these 
are cogent arguments, but from the 
practical point of view, they are 
not significant. Fructose further 
complicates therapy and there may 
be some hazard because in children 
fructose causes massive deposition 
of glycogen in the liver which itself 
might be harmful. The liver be-
comes greatly distended and you 
have the feeling that only the cap-
sule is preventing it from bursting. 
I have said nothing about lavage 
of the stomach or passage of a 
stomach tube. Life is already com-
plex when you have a keto-acidotic 
patient to look after, and passing a 
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tube into an unconscious patient is 
not the easiest thing to do. The 
stomach tube should be put down 
only in those patients who continue 
to vomit. Most patients will not 
continue vomiting if you do not 
give anything by mouth. Whatever 
is in the stomach and gastrointesti-
nal tract will be absorbed as therapy 
continues, so generally it is reason-
able to avoid this additional com-
plication. 
MANAGEMENT AFTER THE 
FIRST FEW HOURS 
We have come now to the sixth, 
seventh or eighth hour and the pa-
tient is responding to treatment in 
a satisfactory fashion. We have seen 
some decrease in the blood sugar, 
some rise in the "C02," some de-
crease in the acetonemia. The urine 
continues to contain sugar; it still 
contains ketone bodies but perhaps 
in reduced quantities. By this time 
the patient is partially restored to 
consciousness, perhaps asking for 
food and fluids by mouth. We can 
begin to relax a little, but we should 
not take the needle out of the vein. 
The patient can be started at this 
point on some intake by mouth. If 
vomiting ensues, this should be dis-
continued. One can alternate tea 
fortified with glucose and sucrose 
and lactose with 0.5 % sodium chlo-
ride broth. The real problem is en-
countered between the 12th and 
24th hour. The difficulties stem 
from the fact that the house staff 
has been working all night long on 
the coma patient; morning arrives, 
and it is time to have the report 
and to make rounds. So everyone 
relaxes as far as attention to the pa-
tient goes. Or, if the house staff has 
worked all day, it is midnight and 
time to go to bed. The nurses are 
very considerate, so they do not re-
port promptly when the glucose in-
fusion is not working properly. 
There are two problems that de-
velop. One is hypoglycemia and the 
other is hypokalemia. Twenty per-
cent of the patients who are in the 
12th to 24th hour of therapy de-
velop blood sugars which are in the 
hypoglycemic range. Approximately 
20 % develop hypokalemia with po-
tassium levels below 3.5 or 3.0 
mEq/ liter. These are the two se-
quelae which undoubtedly account 
for unexplained deaths in comas 
that have been otherwise treated 
very successfully. When the patient 
reaches the 24th hour of treatment, 
usually we put him back on his us-
ual dosage of insulin or on regular 
insulin. With resumption of a nor-
mal dietary intake, the remaining 
deficits are made up. 
MORTALITY 
There is no question that some 
centers have a better record than 
others. Certainly the Joslin Clinic 
record is most impressive with mor-
talities of 1 % , 2 % , or 3 % . It is 
recognized that these low mortality 
rates represent a very selected type 
of experience, under unusually fav-
orable circumstances. The Joslin 
Clinic has a laboratory that is set 
up to look after keto-acidosis seven 
days a week. Unfortunately, in 
many other centers the mortality 
is still high. It ranges between 15 % 
and 25% in adults. The mortality 
in pediatric diabetic coma is much 
less. Indeed, you hardly ever see a 
death in childhood provided the 
diabetes had been recognized previ-
ously, the patient is under therapy, 
and the coma is treated in a quali-
fied institution. But there are still 
deaths in children which result from 
previously undiagnosed diabetes 
terminating in coma, or that result 
from the assumption that all hospi-
tals are equivalent in terms of their 
ability to treat diabetic keto-acidotic 
coma. Properly treated, keto-acido-
sis in children and adults should be 
nothing but an event, certainly an 
avoidable event in many cases, in 
the life of the diabetic. 
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